Business Description
Pliant Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US7291391057
Share Class Description:
PLRX: Ordinary SharesDescription
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.25 | |||||
| Equity-to-Asset | 0.81 | |||||
| Debt-to-Equity | 0.15 | |||||
| Debt-to-EBITDA | -0.33 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -76 | |||||
| 3-Year EBITDA Growth Rate | -12.6 | |||||
| 3-Year EPS without NRI Growth Rate | -12.1 | |||||
| 3-Year FCF Growth Rate | -3.2 | |||||
| 3-Year Book Growth Rate | -0.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | -14.99 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 81.78 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.58 | |||||
| 9-Day RSI | 41.59 | |||||
| 14-Day RSI | 41.3 | |||||
| 6-1 Month Momentum % | -12.15 | |||||
| 12-1 Month Momentum % | -26.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 14.47 | |||||
| Quick Ratio | 14.47 | |||||
| Cash Ratio | 14.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19 | |||||
| Shareholder Yield % | -3.34 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -8847.59 | |||||
| ROE % | -39.62 | |||||
| ROA % | -35.21 | |||||
| ROIC % | -805.51 | |||||
| 3-Year ROIIC % | -2662.56 | |||||
| ROC (Joel Greenblatt) % | -1103.5 | |||||
| ROCE % | -36.9 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 416.28 | |||||
| PB Ratio | 1.73 | |||||
| Price-to-Tangible-Book | 1.73 | |||||
| EV-to-EBIT | -1.63 | |||||
| EV-to-Forward-EBIT | -0.55 | |||||
| EV-to-EBITDA | -1.65 | |||||
| EV-to-Revenue | 189.7 | |||||
| EV-to-Forward-Revenue | 29.97 | |||||
| EV-to-FCF | -2.14 | |||||
| Price-to-Net-Current-Asset-Value | 1.91 | |||||
| Price-to-Net-Cash | 1.97 | |||||
| Earnings Yield (Greenblatt) % | -61.35 | |||||
| FCF Yield % | -20.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PLRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Pliant Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.58 | ||
| EPS (TTM) ($) | -3.09 | ||
| Beta | 1.25 | ||
| Volatility % | 59.53 | ||
| 14-Day RSI | 41.3 | ||
| 14-Day ATR ($) | 0.666894 | ||
| 20-Day SMA ($) | 11.6855 | ||
| 12-1 Month Momentum % | -26.92 | ||
| 52-Week Range ($) | 10.22 - 19.62 | ||
| Shares Outstanding (Mil) | 60.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pliant Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pliant Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pliant Therapeutics Inc Frequently Asked Questions
What is Pliant Therapeutics Inc(PLRX)'s stock price today?
The current price of PLRX is $11.24. The 52 week high of PLRX is $19.62 and 52 week low is $10.22.
When is next earnings date of Pliant Therapeutics Inc(PLRX)?
The next earnings date of Pliant Therapeutics Inc(PLRX) is 2024-11-08 Est..
Does Pliant Therapeutics Inc(PLRX) pay dividends? If so, how much?
Pliant Therapeutics Inc(PLRX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers